Špela Šalamon

415 citations
8 papers · 260 indexed · h-index 6

Impact in

Papers in

Špela Šalamon

7 papers receiving 251 citations

Peers

Špela Šalamon
Comparison fields: 5 of 90
  • Aging 5
  • Pulmonary and Respiratory Medicine 84
  • Biochemistry 16
  • Radiology, Nuclear Medicine and Imaging 49
  • Nutrition and Dietetics 29
Replace Chiemi Sakai with:
Chiemi Sakai Japan
Jiawei Tang China
Elizabeth M Hall United States
Weronika Frąk Poland
Dario Costa Italy
Paola Caielli Italy
Angélica Martínez‐Hernández Mexico
Gaaminepreet Singh India
Asmaa M. A. Bayoumi Egypt
Zahra Jalali Iran
Špela Šalamon relative to Chiemi Sakai Japan Chiemi Sakai's profile →
Citations per field
00.5×1.5×2.5×
Chiemi Sakai · 1×
Citations per year

Countries citing papers authored by Špela Šalamon

Since Specialization
Citations

This map shows the geographic impact of Špela Šalamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Špela Šalamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Špela Šalamon more than expected).

Fields of papers citing papers by Špela Šalamon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Špela Šalamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Špela Šalamon. The network helps show where Špela Šalamon may publish in the future.

Co-authors

The 25 scholars most cited alongside Špela Šalamon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Špela Šalamon Line = papers co-authored together Špela Šalamon links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 20250
2 202416
3 20242
4 20246
5 20215
6 201972
7 2019142
8 201717

About Špela Šalamon

Špela Šalamon is a scholar working on Critical Care and Intensive Care Medicine, Biochemistry, Neurology, Pharmacology and Infectious Diseases, having authored 8 papers that have together received 260 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (2 papers), Genetic Syndromes and Imprinting (1 paper), Genetic Associations and Epidemiology (1 paper), Thermal Regulation in Medicine (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Medical Imaging Techniques and Applications (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Aging (5 citations), Pulmonary and Respiratory Medicine (84 citations), Biochemistry (16 citations), Radiology, Nuclear Medicine and Imaging (49 citations) and Nutrition and Dietetics (29 citations). Špela Šalamon has collaborated with scholars based in United Kingdom, Slovenia and Australia. Frequent co-authors include Borut Poljšak, Irina Milisav, Barbara Kramar, Herbert Kvaternik, Reingard Aigner, Stéphane Bilodeau, Andrew G. Ewing, Yaneer Bar‐Yam, Etheresia Pretorius and Radka Opatřilová. Their work appears in journals such as Antioxidants, Nutrition and Cancer, Genes, Seminars in Thrombosis and Hemostasis and Clinical Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026